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We show here that replication of defective interfering (DI) particle RNA in HEK293 cells stably expressing
vesicular stomatitis virus (VSV) replication proteins potently activates interferon (IFN) and IFN signaling
pathways through upregulation of IFN-␤ promoter, IFN-stimulated response element (ISRE) promoter, and
NF-B promoter activities. Replication of DI particle RNA, not mere expression of the viral replication
proteins, was found to be critical for induction of IFN and IFN signaling. The stable cells supporting
replication of DI RNA described in this report will be useful in further examining the innate immune signaling
pathways and the host cell functions in viral genome replication.
fluorescent protein [eGFP] sequence) (7), and L are each
placed under the control of separate cytomegalovirus (CMV)
promoter and poly(A) sequences (Fig. 1A). Human embryonic
kidney (HEK293) cells were transfected with the pc-NPeGFPL
plasmid, and the cells were treated with G418 at 48 h
posttransfection. Although several cell clones expressing all
three viral proteins were isolated, we selected three cell
clones (293-NPeGFPL cell clone no. 204, 206, and 211) for
further studies. Immunofluorescent staining of the cells
showed that all three viral proteins were expressed in the
majority of the cells in the culture (Fig. 1B). Examination of
expression of the viral proteins by radiolabeling, immunoprecipitation, and SDS-PAGE analyses revealed that each of these
cell clones expressed readily detectable levels of the three viral
proteins (Fig. 1C).
To test the functionality of the viral proteins, we infected the
stable cell clones with DI particles of VSV and examined
replication of DI RNA. Results showed that each of the cell
clones supported efficient DI RNA replication (Fig. 2A). The
levels of DI RNA replication in these cell clones (Fig. 2A,
lanes 3 to 5) were comparable to that seen in the vv-T7 system
(Fig. 2A, lane 1) described previously (19). We had shown
previously that maintaining a certain molar ratio of the three
VSV replication proteins is important for optimal replication
of DI particle RNAs (19). The molar ratios of the VSV proteins in the three cell clones examined are similar to those
obtained in cells infected with VSV expressing PeGFP (Fig.
1C). Furthermore, after 6 months of culture spanning over 60
passages, the cell growth characteristics were similar to those
of the cells not expressing the viral proteins and the cell lines
still supported efficient replication of DI RNA (Fig. 2B). The
stable cells were also capable of supporting assembly and release of infectious DI particles upon coexpression of M and G
proteins (Fig. 2C), confirming our previous findings obtained
using the vv-T7 system (18).
These results suggest that the replication proteins of VSV

For most of the negative-strand RNA viruses, including vesicular stomatitis virus (VSV), rescue of infectious viruses by
using full-length cDNA clones, as well as examination of the
roles of cis-acting signals and trans-acting functions in genome
replication and transcription, has been well documented (6,
17). However, in the majority of these systems, expression of
the viral proteins from support plasmids in transfected cells is
driven by T7 RNA polymerase supplied by infecting the cells
with the recombinant vaccinia virus expressing the T7 polymerase (vv-T7). In such systems, due to the cytopathic effects of
vaccinia virus, examination of the effects of replication of viral
genomes, genomic analogs, or defective interfering (DI) particle genomes on host gene expression or the effects of host cell
functions on viral genome replication and transcription has
been difficult. Additionally, since VSV and many other negative-strand RNA viruses exhibit overt cytopathic effects in infected cells due to the expression of viral proteins, it is not
possible to study the long-term effects of viral genome replication and/or transcription on host cell functions. Therefore,
development of cells capable of supporting replication and
maintenance of the viral genomes on a long-term basis is highly
desirable. Such systems could alleviate the limitations described above and allow us to study the interplay between the
host and viral functions in the absence of the viral M and G
proteins.
Efficient replication of DI particle RNA in cells constitutively expressing VSV replication proteins. The N, P, and L
proteins of VSV are the replication proteins. To generate
stable cell lines expressing these proteins, we constructed a
plasmid (pc-NPeGFPL) in which the coding sequences for N,
PeGFP (a functional P protein fused with an enhanced green
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FIG. 1. (A) Schematic representation of the plasmid pc-NPeGFPL, expressing the VSV N, PeGFP, and L proteins. Coding sequences for N,
PeGFP, and L were cloned under the control of a CMV immediate-early promoter and poly(A) signal in the pcDNA 3.1-neo vector backbone.
The CMV promoter and poly(A) signal sequences for N and PeGFP were derived from the pHygEGFP vector. Coding sequences for N, PeGFP,
and L are shown in blue, green, and red, respectively. An ampicillin resistance (Ampr) gene, a neomycin resistance (Neor) gene, a simian virus 40
(SV40) promoter and origin of replication (O), the CMV promoter (pCMV), and polyadenylation signal sequences (pA) are shown. Further details
of the construction of the pc-NPeGFPL plamsid can be obtained upon request. (B) Detection of VSV proteins in stable cell clones by
immunofluorescence microscopy. Cells from stable cell clone no. 204 were simultaneously immunostained with anti-N monoclonal antibody (10G4)
and anti-L peptide antibody and subsequently with goat anti-mouse Alexa 647 and donkey anti-rabbit Alexa 594 secondary antibodies. Cells were
mounted and observed under an inverted confocal microscope. (a) Epifluorescence microscopy image of cells expressing PeGFP; (b and c)
immunofluorescence images of the same cells expressing the N protein (pseudoblue color) (b) and the L protein (red) (c). Panel d shows the
merged images from panels a, b, and c. A differential interference contrast (DIC) image of the cells is shown in panel e. (C) Expression of VSV
proteins in different cell clones. G418-resistant stable cell clones 204, 206, and 211 (lanes 2 to 4), as well as stable 293-pcDNA cells transfected
with the pcDNA 3.1 vector (lane 1), were radiolabeled with Expre35S35S protein labeling mix. The radiolabeled proteins were immunoprecipitated
with anti-VSV antibody, analyzed by SDS-PAGE, and detected by fluorography. Radiolabeled proteins from HEK293 cells infected with VSV
expressing PeGFP (lane 5) or wild-type VSV (VSVwt) (lane 6) are also shown. Viral proteins are identified to the right.

can be constitutively expressed without any adverse effects on
cell growth and viability and that they can form functional
polymerase complexes to support replication of RNA and assembly of infectious DI particles.
DI RNA replication activates the IFN-␤ promoter. Activation of double-stranded RNA (dsRNA) signaling and subsequent interferon (IFN) production by both VSV and VSV DI
particles has been well documented (4, 13, 15). VSV M protein
is known to shut off host cellular mRNA synthesis and nucleocytoplasmic transport of RNAs (1, 8, 10, 26) and thereby inhibit IFN production (9). The availability of a vaccinia virusfree system that supports DI RNA replication provides us a
unique opportunity to examine the effects of DI RNA on host
cell functions, particularly the activation of innate immune
signaling pathways in the absence of the viral M protein. DI
particle infection of the control cell line not expressing the viral
proteins (293-pcDNA cells) yielded only basal-level induction (1.3-fold) of IFN-␤ promoter activity compared to that
in uninfected cells. However, in cells expressing the replication proteins (293-NPeGFPL cells), DI particle infection
and subsequent DI RNA replication resulted in activation of

the IFN-␤ promoter by as much as 67-fold over that in
uninfected cells and 50-fold over that in DI particle-infected
control 293-pcDNA cells (Fig. 3A). Additionally, activation
of the IFN-␤ promoter in 293-NP cells (expressing only the
N and P proteins) infected with DI particles was not detected (Fig. 3B). We could demonstrate replication of DI
RNA only in 293-NPeGFPL cells and not in 293-pcDNA
control cells or in 293-NP cells (Fig. 3A and B). These
results suggest that replication of DI RNA, not entry and
uncoating of DI RNA or mere expression of the viral replication proteins per se, activates the IFN-␤ promoter.
A kinetic analysis of IFN-␤ promoter activation further revealed that, indeed, only replication of DI RNA induced the
activation of the IFN-␤ promoter. In 293-pcDNA cells, DI
particle infection resulted in only basal-level IFN-␤ promoter
activity, while in 293-pcNPeGFPL cells infected with DI particles, IFN-␤ promoter activity increased with time postinfection (Fig. 3C). The level of DI RNA at 2 h postinfection (as
determined by reverse transcription-PCR [RT-PCR] analysis)
was below the level of detection (Fig. 3C, bottom), but a
significant increase (7-fold) in IFN-␤ promoter activity over
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FIG. 2. Replication of DI particle RNA genomes in 293-NPeGFPL cell clones. (A) Cell clones 204, 206, and 211 (lanes 3, 4, and 5, respectively)
or 293-pcDNA control cells (lane 2) grown in 60-mm dishes were infected with DI particles and radiolabeled with [3H]uridine. Radiolabeled DI
RNA was recovered from cell extracts by immunoprecipitation with anti-N antibody, analyzed by agarose-urea gel electrophoresis, and detected
by fluorography as described previously (19). Lane 1 shows DI RNA replication products obtained from BHK-21 cells by using the vv-T7 system.
DI RNAs (negative and positive sense) are identified to the right. (B) DI RNA replication in stable cell clones after 60 passages (approximately
6 months) in culture. The experimental protocol was the same as that described in the legend to panel A. (C) Rescue of DI particles from cells
supporting DI RNA replication following expression of M and G proteins. Cells from clone 206 were infected with DI particles. After 6 h of
infection, the cells were infected with vaccinia virus vTF7-3 and were subsequently transfected with the pGEM-3 vector (lane1), the plasmid
encoding the M protein (lane 2), the plasmid encoding the G protein (lane 3), or the plasmids encoding the M and G proteins (lane 4) as described
previously (18). Supernatants from cells collected 12 to 14 h posttransfection were used to infect fresh cells of stable 293-NPeGFPL clone 206. The
cells were radiolabeled with [3H]uridine and processed as described in the legend to panel A to detect DI particles by using an RNA replication
assay. Lane 5 shows the DI RNA replication products obtained from BHK-21 cells by using the vv-T7 system as described in the legend to panel
A. DI RNAs (negative and positive sense) are identified to the right. Parallel samples were analyzed for expression of M protein and G protein
by Western blotting (WB) with appropriate antibodies, and results are shown in the bottom panels.

that in similarly infected control cells could be readily seen. As
the time postinfection with DI particles increased, IFN-␤ promoter activity also increased, concomitant with increased DI
RNA replication (Fig. 3C, bottom). Since in cells expressing
only the viral N and P proteins and infected with DI particles
(a condition under which DI RNA replication does not occur),
activation of the IFN-␤ promoter was not observed, the results
of our studies demonstrate that IFN-␤ promoter activation
requires DI RNA replication. Together, the findings that the
mere expression of the three replication proteins did not activate the IFN-␤ promoter and that we could not detect RNP
formation with cellular RNAs in the presence of N, PeGFP,
and L proteins (data not shown) strengthen our conclusion
that only replication of DI RNA induces IFN-␤.
DI RNA replication activates the ISRE promoter and the
NF-B promoter. In contrast to the IFN-␤ promoter, the IFNstimulated response element (ISRE) promoter contains two
ISREs which can be activated by IFN regulatory factor 3
(IRF3), IRF7, or both (22). To elucidate the effect of DI RNA
replication upon IRF3-mediated signaling, we used an ISRE
promoter-driven luciferase reporter plasmid. DI particle infection of 293-pcDNA control cells led to a meager 1.7-fold increase in luciferase activity over that in the corresponding
uninfected cells (Fig. 4A). However, DI particle infection of
293-NPeGFPL cells resulted in greater than 200-fold induction
of luciferase activity over that in the uninfected 293-NPeGFP

cells (Fig. 4A). Activation of IFN-␤ gene transcription requires
coordinate actions of IRF3, NF-B, and ATF-2/c-Jun transcription factors (27). Nearly 40-fold induction of NF-B promoter activity in 293-NPeGFPL cells infected with DI particles
compared to that in similarly infected 293-pcDNA cells was
observed (Fig. 4B). For direct verification of IFN-stimulated
gene expression, we examined the expression of IFN-stimulated gene 56 (ISG56), one of the viral stress-inducible genes
that are induced by IFNs, dsRNA, and virus infections (24).
Results (Fig. 4C) showed strong induction of ISG56 protein
expression in 293-NPeGFPL cells infected with DI particles
(lane 4), whereas in uninfected 293-NPeGFPL cells and in
293-pcDNA cells with or without DI particle infection, ISG56
protein was undetectable. In each of the above-described studies, DI RNA replication products were readily detected (data not
shown). Taken together, the results from the above-described
studies show that replication of DI RNA in 293-NPeGFPL cells
potently activates IFN and IFN signaling.
In summary, we report here the establishment of stable cells
expressing the VSV replication proteins. Although a stable cell
line expressing Sendai virus replication proteins has been described previously (28), this is the first description of a cell line
constitutively expressing the VSV replication proteins. Using
this cell line, we have shown that replication of DI RNA
activates IFN and IFN signaling pathways. It has been reported
previously that snap-back DI (⫾) particles of VSV activate
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FIG. 3. Induction of IFN by replication of DI RNA. (A) Stable 293-NPeGFPL cell clone 206, expressing N, PeGFP, and L proteins, or
293-pcDNA control cells, not expressing the viral proteins, were cotransfected with 0.4 g of IFN-␤–Luc along with 10 ng of pRL-TK (a Renilla
luciferase plasmid from Promega, which served as an internal control for transfection efficiency). At 24 h posttransfection, the cells were either
mock infected or infected with DI particles. At 16 h postinfection, the cells were lysed in buffer (Promega), and a luciferase assay was performed
using a Dual-Luciferase assay kit (Promega). Luciferase activity results were expressed as the relative induction (n-fold) over the level of activity
in uninfected 293-pcDNA control cells after normalization with respect to Renilla luciferase activity. Data from three independent experiments are
presented, with standard deviations indicated by error bars. [3H]uridine-radiolabeled samples from a similar experiment were also analyzed for
replication of the DI RNA genome as described in the legend to Fig. 2A, and results are shown in the lower panel. DI RNAs (negative and positive
sense) are identified to the right. (B) (Top) HEK293 cells stably expressing N and P proteins or N, PeGFP, and L proteins were transfected with
luciferase reporter plasmids as described in the legend to panel A and then infected with DI particles. Luciferase activity in the samples was
analyzed at 12 h postinfection with DI particles as described in the legend to panel A and expressed as the change (n-fold) from that in 293-pcDNA
control cells. Data from three independent experiments are presented, with standard deviations indicated by error bars. (Bottom) Parallel sets of
samples were analyzed for DI RNA replication products by RT-PCR. As a control for similar amounts of total RNA being used in the analysis,
RT-PCR products for ribosomal protein L32 are also shown. Representative data for DI RNA replication and ribosomal protein L32 mRNA
quantitation are shown. (C) Kinetics of IFN-␤ promoter activation. The experimental protocol was the same as that described in the legend to
panel B, except that the samples were collected at various times (0, 2, and 12 h for 293-pcDNA cells and 0, 2, 4, 8, and 12 h for 293-NPeGFPL
cells) postinfection with DI particles. Luciferase activity in the samples was measured and expressed as the change (n-fold) from that in 293-pcDNA
control cells. Replication of DI RNA was measured as described in the legend to panel B. hpi, hours postinfection.

IFN signaling. Furthermore, a preexisting molecule in the
snap-back DI genome (presumably a dsRNA structure) has
been proposed to be responsible for induction of IFN, as heat
inactivation or UV treatment of DI particles did not inhibit
IFN induction in chicken embryo fibroblasts and mouse L cells
(15, 23). Contrary to these findings, our results revealed that
replication of DI particle T RNA with a panhandle-type DI

genome (16) is required for IFN-␤ activation as well as IFN
signaling. Mere entry and uncoating of DI particles or expression of only the viral replication proteins was not sufficient to
induce IFN-␤ or IFN signaling. VSV DI genomes are synthesized in the form of nucleocapsid, and possible formation of
dsRNA structures in infected cells has not been reported. Viral
replication intermediates like dsRNA or single-stranded RNAs
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Since infection of cells with VSV and many other negativestrand RNA viruses results in cytopathogenesis and cell death,
it is difficult to study the long-term effects of virus replication
on host cell functions in the context of virus infection. VSVs
encoding mutant M proteins have been used to study IFN
activation (2, 3, 14), but these viruses are also cytopathic.
Therefore, results from studies of the effects of VSV RNA
replication on IFN activation and signaling in the context of
VSV infection are difficult to assess. Our system will provide
the opportunity to examine the effects of viral genome replication on host cell functions in the absence of the cytopathogenic effects of VSV M and G proteins.
We thank Charles Kuszynski, University of Nebraska Medical Center, for help with fluorescence-activated cell sorter analysis. We also
thank Y. Zhou and Terry Fangman, UNL, for help in confocal microscopy. We thank D. Lyles, S. Sarkar, and M. Schubert for antibodies
and reagents.
This investigation was supported by Public Health Service grant
AI-34956 from the National Institutes Health.
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